RedHill Biopharma Net Debt Growth & History (RDHL)
RedHill Biopharma's net debt was −$2.9M for fiscal 2025.
View full RedHill Biopharma company overviewRedHill Biopharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$2.9M | $1.4M | — |
| 2024 | 2024-12-31 | −$4.3M | $135,000 | — |
| 2023 | 2023-12-31 | −$4.4M | −$107.1M | — |
| 2022 | 2022-12-31 | $102.7M | $44.4M | +76.08% |
| 2021 | 2021-12-31 | $58.3M | $730,000 | +1.27% |
| 2020 | 2020-12-31 | $57.6M | $82.8M | — |
| 2019 | 2019-12-31 | −$25.2M | — | — |
RedHill Biopharma quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$2.9M | $1.4M | — |
| Q2 2025 | 2025-06-30 | −$2.7M | $4.1M | — |
| Q4 2024 | 2024-12-31 | −$4.3M | $135,000 | — |
| Q2 2024 | 2024-06-30 | −$6.7M | −$2.0M | — |
| Q4 2023 | 2023-12-31 | −$4.4M | −$107.1M | — |
| Q2 2023 | 2023-06-30 | −$4.7M | −$71.4M | — |
| Q4 2022 | 2022-12-31 | $102.7M | $44.4M | +76.08% |
| Q2 2022 | 2022-06-30 | $66.7M | $30.6M | +85.10% |
| Q4 2021 | 2021-12-31 | $58.3M | $730,000 | +1.27% |
| Q2 2021 | 2021-06-30 | $36.0M | −$26.3M | −42.23% |
| Q4 2020 | 2020-12-31 | $57.6M | $82.8M | — |
| Q2 2020 | 2020-06-30 | $62.3M | $67.3M | — |
| Q4 2019 | 2019-12-31 | −$25.2M | — | — |
| Q2 2019 | 2019-06-30 | −$4.9M | — | — |
RedHill Biopharma net debt trends
Over the last five fiscal years, RedHill Biopharma's net debt decreased from $57.6M to −$2.9M, a change of −$60.5M. The latest reported quarter, Q4 2025, shows −$2.9M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RedHill Biopharma source filings ↗